The Potential of Dietary Bioactive Compounds against SARS-CoV-2 and COVID-19-Induced Endothelial Dysfunction

Jack N Losso1

  • 1School of Nutrition and Food Sciences, Louisiana State University, Baton Rouge, LA 70803, USA.

Insights

COVID-19 is an endothelial disease where comorbidities like obesity and diabetes worsen outcomes. Dietary interventions targeting endothelial dysfunction may prevent severe outcomes from SARS-CoV-2 infection.

Area of Science:

  • Cardiovascular Science
  • Infectious Disease Epidemiology
  • Nutritional Science

Background:

  • COVID-19 is increasingly recognized as an endothelial disease.
  • Major comorbidities associated with severe COVID-19, including old age, obesity, diabetes, and hypertension, are linked to endothelial dysfunction.
  • Genetics and environmental factors contribute to endothelial dysfunction, increasing susceptibility to severe SARS-CoV-2 infection.

Purpose of the Study:

  • To review the role of endothelial dysfunction in COVID-19 severity.
  • To identify dietary risk factors for endothelial dysfunction.
  • To explore dietary bioactives that may prevent endothelial dysfunction and mitigate SARS-CoV-2 infection severity.

Main Methods:

  • Literature review of studies on COVID-19, endothelial function, comorbidities, and nutrition.
  • Analysis of existing research on dietary interventions and their impact on endothelial health.
  • Identification of specific dietary compounds with potential therapeutic benefits.

Main Results:

  • Endothelial dysfunction is a common factor across major COVID-19 risk comorbidities.
  • Modifiable risk factors for endothelial dysfunction include diet, obesity, and hypertension.
  • Several dietary bioactives show efficacy against dysfunctional endothelial cells and SARS-CoV-2 infection.

Conclusions:

  • Endothelial dysfunction is central to severe COVID-19 outcomes.
  • Dietary strategies targeting endothelial health represent a promising avenue for preventing severe SARS-CoV-2 infection.
  • Further research into dietary bioactives is crucial for developing effective nutritional interventions against COVID-19 variants.